Dawn Project Report to Congress Links Tesla's FSD to 59 Deaths, Escalating Regulatory Risk

What happened

A public safety group, The Dawn Project, delivered a report to Congress documenting 59 deaths involving Tesla's Full Self-Driving software and urging three specific regulatory reforms. This report amplifies existing regulatory headwinds, including NHTSA's ongoing Engineering Analysis EA26002 into FSD collisions in reduced visibility and a separate probe into traffic-law violations. While Tesla's Q1'26 filing highlighted growing autonomy KPIs (1.28M active FSD subscriptions, Robotaxi miles nearly doubled), it also disclosed one-time profit benefits and rising inventory days-of-supply. The report adds tangible evidence to the regulatory case against unsupervised expansion, potentially delaying Robotaxi scaling and weighing on the autonomy-premium valuation. The market already prices in a 12-18 month timeline for autonomy monetization, but this report raises the probability of mandated restrictions that could lengthen that timeline.

Implication

Investors should expect heightened near-term volatility as the market digests the report's potential to accelerate regulatory action (NHTSA remedies or congressional hearings). The report does not change the fundamental investment case but adds weight to the bear case (30% probability, $260 target) where regulatory constraints limit unsupervised Robotaxi expansion. For committed bulls, the report underscores the need for Q2'26 evidence of sustained paid Robotaxi miles growth and regulatory clearance to offset this negative catalyst. The WAIT rating is reaffirmed, with a tighter entry point at $320 and a re-assessment window of 3-6 months contingent on Q2'26 results and NHTSA progress. Position sizing should account for the now-higher probability of a regulatory-driven downside scenario.

Thesis delta

The Dawn Project report does not alter the core thesis that Tesla's valuation depends on autonomy monetization within 12-18 months, but it materially increases the perceived risk of regulatory intervention, reducing confidence in the bull case timeline. The report's documentation of 59 FSD-related deaths provides independent ammunition for regulators to impose restrictions, which aligns with our existing thesis breaker on NHTSA EA26002. This shifts probability weight from the bull case (25%) toward the bear case (30%) and reinforces the case for a WAIT stance until cleaner evidence of regulatory progress or Robotaxi scaling emerges.